Filing Details

Accession Number:
0001179110-15-004891
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-13 17:29:04
Reporting Period:
2013-10-31
Filing Date:
2015-03-13
Accepted Time:
2015-03-13 17:29:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1570003 C. Katherine Doyle 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2013-10-31 102 $36.71 43,429 No 4 P Direct
Common Shares Without Par Value Acquisiton 2013-12-03 4 $37.50 43,433 No 4 P Direct
Common Shares Without Par Value Disposition 2014-02-03 1 $35.93 43,432 No 4 S Direct
Common Shares Without Par Value Acquisiton 2014-03-14 52 $39.11 43,484 No 4 P Direct
Common Shares Without Par Value Disposition 2014-04-15 10 $37.58 43,474 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 S Direct
No 4 P Direct
No 4 S Direct
Footnotes
  1. Purchase was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 200 shares of Abbott common shares at a price of $39.015 per share (including transaction costs), or $38.999 per share (excluding transaction costs), which was reported on March 4, 2014. The reporting person has paid to Abbott $239.70, representing the full amount of the profit realized in connection with these transactions, less transaction costs.